Research & Development: Page 98
-
PharmaVoice Team/PharmaVoice
What's New
New Healthcare-related Products, Services, and Companies Scientific Advantage Launches MSL Outsourcing Subsidiary The new division addresses client requests for MSL professionals. Scientific Advantage LLC has formed MSL Advantage LLC to fill MSL staffing positions within pharmaceutical, biotech, ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Discovery Bug -- Dr. Graham Allaway
By Kim Ribbink Graham Allaway, Ph.D. Whether Dr. Allaway is exploring the open seas in his single-handed Laser or investigating uncharted areas in virology, he attends to both with equal passion, commitment, and focus. In small companies, people are pulling in the same direction; it’s truly a tea...
By Kim Ribbink • Jan. 2, 2008 -
Explore the Trendlineâž”
Getty Images
TrendlineArtificial intelligence & machine learning
After years of excited buzz around the potential of artificial intelligence and machine learning, pharma has begun to realize the true implications and potential value of these technologies.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
IRBs The Safety Gatekeepers
By Denise Myshko Current pressures to speed drugs to market have resulted in the increased use of independent, centralized institutional review boards as an alternative to academic IRBs, because they can offer faster and more efficient protocol reviews. Institutional review boards, or IRBs, are a...
By Denise Myshko • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Pharma Has The Data But Not The Information
Michael Rosenberg, M.D., MPH, President and CEO of Health Decisions Inc., Chapel Hill, N.C., discusses why, compared with other large industries, pharma’s automation processes lag behind. Are you involved with clinical research? If so, take a moment to imagine what if every clinical research assi...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Nanotech Sector Continues Strong Growth Sales, Marketing, and R&D Trends from Industry Analysts The commercialization of nanotechnology continues to gain momentum worldwide, according to The Nanotech Report, 4th Edition, a comprehensive and up-to-date reference study on nanotechnology, releas...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
DIA 2006 -- Annual Conference
DIA 2006 — Breaks Attendance Records September 2006 Sanjay Gupta, M.D., senior medical correspondent for the health and medical unit at CNN, practicing neurosurgeon, and an assistant professor of neurosurgery gave the keynote speech at the 42nd Annual DIA Meeting. The conference drew record numbe...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Global Perspective
Staffing Multinational Trials A Time for Creative Solutions In the past decade, an unprecedented push to field Global clinical trials has boosted the demand for patients and CRAs from Asia to Zambia. Sponsors expect rock-bottom pricing, transparency, local staff with a breadth of experience, and ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
UpFront
Consumers Talk Back Countering DTC Criticism Challenging many of the assumptions of both academic and public-policy critics of DTC, CommonHealth filed a research report with the FDA based on analysis of 440 transcripts of actual provider-patient interactions in community-practice settings recorde...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Cover
A Team Approach Breaking Down the Silos Debugging the Pipeline with Graham Allaway, Ph.D. Name that Brand Clinical Gatekeepers: Institutional Review Boards The Forum for the Industry Executive September 2006 Volume 6 Number 8 Download PDF
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Ben Franklin and Taren Grom at the MediciGroup booth at the 42nd Annual Drug Information Association meeting in Philadelphia. An innovative approach Many consider Ben Franklin to be one of America’s most prolific inventors. Throughout his colorful life, Ben Franklin pursued scientific knowledge w...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Integrating Outcomes Studies Into Medical Education
August 2006 VIEW on Medical Education Outcomes measurement Integrating Outcomes Studies Into Medical Education CME LLC, Irvine, Calif., is dedicated to providing high-quality, life-long learning opportunities for clinicians through a variety of convenient learning formats. For more infor...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Solutions to Bridging the Cross-Cultural Divide in Healthcare
Solutions to Bridging the Cross-Cultural Divide in Healthcare Program Development Sudler & Hennessey AnneMarie Armani, M.D. Senior Medical Director, Imprint Science Daria Blackwell Consultant, Sudler Multicultural Education Ruben Gutierrez Director, Sudler Multicultural Education ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Why Physicians Learn
Why Physicians Learn Program Development David St. Peter, M.D., Executive VP/Managing Director Customer insights, such as having unique perspectives into what motivates an audience to learn, are critical to the development of successful programs that effectively change behavior. Some may s...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Building a Successful Partnership Between Medical Education Companies and Recruitment Vendors
Building a Successful Partnership Between Medical Education Companies and Recruitment Vendors Partnerships Judy Hagan General Manager and Senior VP of Sales and Marketing Having weathered the changing landscape of CME, it has become abundantly clear that MECs c...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Measuring Educational Outcomes in CME
August 2006 VIEW on Medical Education Postgraduate Institute for Medicine Outcomes measurement Measuring Educational Outcomes in CME Jan Schultz, RN, MSN Director, Educational Outcomes and Accreditation Michael R. Lemon, MBA President Commercial supporters want their grant dollar...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Making the Ordinary Satellite Symposium Extraordinary
Making the Ordinary Satellite Symposium Extraordinary Fission Communications Event Planning Mario R. Nacinovich Jr. Senior VP, Chief Creative Officer James A. Karcher Senior Director, Strategic Planning and Business Development Richard L. Abbot Jr. Group Business Director Th...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Researchers & Scientists
Dr. Daniel P. Getman A Scientific Home Run A leading scientist and a respected spokesperson, Daniel Getman, Ph.D., is a strong advocate for the value of pharmaceutical innovation. His extensive insight into medicinal chemistry has made Dr. Getman, VP of global research and development, director, ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Technologists
These technology leaders are taking computer-based and enabled solutions to the next plateau and in doing so they are reducing the time needed to conduct clinical trials, cutting the cost of clinical development, and ensuring that the products that do make it to market are properly evaluated for ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Mentors
The Mentors These outstanding individuals unselfishly give of their time and provide their insights to mentor the next generation of business leaders. July/August 2006 PharmaVOICE 100 Kathleen Case Paddling in One Direction For Kathleen Case, directing a group of 23 professionals as her first for...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Cover
100 of the most inspiring people July/August 2006 PharmaVOICE pharmavoice.com Volume 6 Number 7 Download PDF
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Change Agents
The Change Agents Not content with the status quo, these individuals have decided to shift the paradigm in their fields and are impacting business processes, technologies, and strategies across the life-sciences industry. Mark Bard Keeping the Focus on Results Education B.S. in health administrat...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Meet the R&D Leaders
By Denise Myshko Executives charged with R&D responsibilities within biotech and pharmaceutical organizations, both large and small, face myriad opportunities and challenges. Drug development is a costly and risky business. The pharmaceutical industry is challenged by many factors related to ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
A Rising Tide for Clinical Services
A Rising Tide for Clinical Services By Daniel Limbach June 2006 VIEW on Clinical Services Contract drug-development expenditures were $19 billion in 2005 and are expected to increase at an annual rate of 17%, eventually exceeding $42 billio...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Who's on the List -- 2006
Indexed by Section The Commanders and Chiefs Carol Ammon Diana Anderson, Ph.D. John Benbrook Mark Booth Kurt Brykman Thomas Buckley John J. Campbell William Clapper William Claypool, M.D. Nicholas Colucci William H. Crown, Ph.D. Phil Deschamps Susan Desmond-Hellmann, M.D. Fereydoun Firouz Ginger ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Who's on the List -- 2006
AbelsonTaylor Jay Carter Advanced Health Media Kevin McMurtry Algorithmic Research Inc. Gadi Aharoni, Ph.D. Ambit Biosciences M. Scott Salka Amgen Inc. Kevin Sharer Amylin Pharmaceuticals Inc. Ginger Graham Archives of Internal Medicine and Archives of Dermatology Patricia Quilty AstraZeneca Barr...
By PharmaVoice Team • Jan. 2, 2008
Previous
